Medgenics, Inc. Extends Collaboration with Baxter Healthcare Corporation on Development of Factor VIII Biopump

Published: Jul 06, 2011

MISGAV, Israel and VIENNA, Va.--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) announces an extension of its agreement with Baxter Healthcare Corporation for the joint development of the Factor VIII Biopump.

Back to news